<bill session="108" type="h" number="3155" updated="2013-07-14T19:01:59-04:00">
  <state datetime="2003-09-23">REFERRED</state>
  <status>
    <introduced datetime="2003-09-23"/>
  </status>
  <introduced datetime="2003-09-23"/>
  <titles>
    <title as="introduced" type="short">Fair Balance Prescription Drug Advertisement Act of 2003</title>
    <title as="introduced" type="official">To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, and to amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements.</title>
  </titles>
  <sponsor id="400387"/>
  <cosponsors>
    <cosponsor id="400026" joined="2004-03-31"/>
    <cosponsor id="400069" joined="2004-03-31"/>
    <cosponsor id="400120" joined="2003-09-23"/>
    <cosponsor id="400133" joined="2004-03-31"/>
    <cosponsor id="400162" joined="2003-09-23"/>
    <cosponsor id="400178" joined="2004-03-31"/>
    <cosponsor id="400262" joined="2004-03-31"/>
    <cosponsor id="400263" joined="2004-03-31"/>
    <cosponsor id="400295" joined="2004-03-31"/>
    <cosponsor id="400360" joined="2004-03-31"/>
    <cosponsor id="400378" joined="2004-03-31"/>
    <cosponsor id="400436" joined="2003-10-28"/>
  </cosponsors>
  <actions>
    <action datetime="2003-09-23">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1862-1863"/>
    </action>
    <action state="REFERRED" datetime="2003-09-23">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-09-23">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2003-09-23">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-10-06">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Commerce"/>
    <term name="Consumer education"/>
    <term name="Costs"/>
    <term name="Deceptive advertising"/>
    <term name="Drug advertising"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Tax deductions"/>
  </subjects>
  <amendments/>
  <summary>9/23/2003--Introduced.
Fair Balance Prescription Drug Advertisement Act of 2003 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.</summary>
</bill>
